Takeda Pharmaceutical/TAK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Takeda Pharmaceutical
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Ticker
TAK
Sector
Healthcare
Trading on
NYSE
Industry
Biotechnology & Drugs
Headquarters
Chuo-ku, Japan
Employees
49,095
Website
www.takeda.com
TAK Metrics
BasicAdvanced
$42B
Market cap
46.05
P/E ratio
$0.29
EPS
0.59
Beta
-
Dividend rate
7.18%
Dividend yield
Price and volume
Market cap
$42B
Beta
0.59
52-week high
$16.39
52-week low
$12.77
Average daily volume
33
Financial strength
Current ratio
1.106
Quick ratio
0.583
Long term debt to equity
61.547
Total debt to equity
66.597
Dividend payout ratio (TTM)
102.76%
Enterprise value to free cash flow
105.447
Interest coverage (TTM)
2.20%
Management effectiveness
Return on assets (TTM)
0.99%
Return on equity (TTM)
2.11%
Return on investment (TTM)
1.19%
Valuation
Price to earnings (TTM)
46.052
Price to revenue (TTM)
1.554
Price to book
0.906
Forward dividend yield
7.18%
Growth
Revenue change (TTM)
5.87%
Earnings per share change (TTM)
-55.06%
3-year revenue growth
10.06%
3-year earnings per share growth
-27.23%
What the Analysts think about TAK
Analyst Ratings
Majority rating from 4 analysts.
TAK Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
¥1.1T
-5.43%
Net income
-¥3B
-102.85%
Profit margin
-0.28%
-102.94%
TAK Earnings Performance
No data availble
Quarterly data is not available. You can look at the annual data instead.
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Actual
Expected
Surprise
TAK News
AllArticlesVideos
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease
Business Wire·2 months ago
Takeda Pharmaceutical Company Limited (TAK) Fiscal Year 2023 Earnings Call Transcript
Seeking Alpha·2 months ago
Takeda Pharmaceuticals earnings: profits, EPS down over 50% in Q4 financial results
Invezz·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractionalADR
Upcoming events
Jul
8
Takeda Pharmaceutical
Dividend·Payment
$0.292214
Per share
FAQs
What’s the current market cap for Takeda Pharmaceutical stock?
Takeda Pharmaceutical (TAK) has a market cap of $42B as of July 03, 2024.
What is the P/E ratio for Takeda Pharmaceutical stock?
The price to earnings (P/E) ratio for Takeda Pharmaceutical (TAK) stock is 46.05 as of July 03, 2024.
Does Takeda Pharmaceutical stock pay dividends?
No, Takeda Pharmaceutical (TAK) stock does not pay dividends to its shareholders as of July 03, 2024.
When is the next Takeda Pharmaceutical dividend payment date?
Takeda Pharmaceutical (TAK) stock does not pay dividends to its shareholders.
What is the beta indicator for Takeda Pharmaceutical?
Takeda Pharmaceutical (TAK) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Takeda Pharmaceutical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.